Lin BioScience, Inc. (6696.TWO)
TWD 139.5
(4.1%)
TWD 139.5
(4.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -1.01 Billion | -361.01 Million | -289.83 Million | -180.6 Million | -209.66 Million |
| Net Income | -1.09 Billion | -477.87 Million | -490.41 Million | -174.79 Million | -235.25 Million |
| Depreciation & Amortization | 17.92 Million | 11.15 Million | 4.39 Million | 4.07 Million | 4.31 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 115.15 Million | 44.39 Million | 8.91 Million | 925 Thousand | - |
| Change in working capital | -80.39 Million | 2.12 Million | 26 Million | -11.36 Million | 19.78 Million |
| Other non-cash items | -3.27 Million | -231 Thousand | -122 Thousand | -241 Thousand | 2.13 Million |
| Investing Cash Flow | 1.86 Million | -24.05 Million | -1.47 Million | 204 Thousand | 98.95 Million |
| Investments in PPE | -1.96 Million | -22.38 Million | -2.12 Million | -573 Thousand | -2.34 Million |
| Acquisitions | 2.02 Billion | 624.32 Million | 510 Thousand | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 101.21 Million |
| Other Investing Activities | -518 Thousand | -2.82 Million | -55 Thousand | 283 Thousand | 85 Thousand |
| Financing Cash Flow | 2.63 Billion | 1.12 Billion | 28.31 Million | 1.16 Billion | 57.55 Million |
| Debt repayment | -11.85 Million | - | - | - | -59.96 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 622.4 Million | 510.99 Million | 31.22 Million | 915.26 Million | - |
| Other Financing Activities | 2.02 Billion | 624.32 Million | - | - | - |
| Accounts receivables | -25.01 Million | 1.45 Million | -1.48 Million | - | 7.98 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -55.37 Million | 661 Thousand | 27.49 Million | -11.36 Million | 11.79 Million |
| Cash at beginning of period | 1.64 Billion | 806.84 Million | 1.09 Billion | 117.14 Million | 167.99 Million |
| Cash at end of period | 3.26 Billion | 1.64 Billion | 806.84 Million | 1.09 Billion | 117.14 Million |
| Capital Expenditure | -1.96 Million | -22.38 Million | -2.12 Million | -573 Thousand | -2.34 Million |
| Effect of forex changes on cash | -10.13 Million | 93.66 Million | -22.4 Million | -4.85 Million | - |
| Net cash flow / Change in cash | 1.61 Billion | 838.38 Million | -285.4 Million | 975.1 Million | -50.84 Million |
| Free Cash Flow | -1.01 Billion | -383.39 Million | -291.95 Million | -181.18 Million | -212 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -173.41 Thousand | -173.41 Thousand | -384.82 Million | -1.09 Billion | -192.41 Thousand | -302.36 Million |
| Depreciation & Amortization | 4807.50 | 4807.50 | 9.38 Million | 17.92 Million | 4693.00 | 8.54 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 28.35 Thousand | 28.35 Thousand | - | 115.15 Million | 50.76 Thousand | - |
| Change in working capital | 1513.50 | 1513.50 | -106.18 Million | -80.39 Million | -50.76 Thousand | 25.78 Million |
| Other non-cash items | -148.67 Thousand | -148.67 Thousand | -80.52 Million | -3.27 Million | -116.6 Thousand | -117.42 Million |
| Investing Cash Flow | -1.46 Million | -1.46 Million | 1.34 Billion | 1.86 Million | 359.00 | 683.71 Million |
| Investments in PPE | -1760.00 | -1760.00 | -1.96 Million | -1.96 Million | -982.50 | - |
| Acquisitions | 1.24 Billion | - | 1.34 Billion | 2.02 Billion | - | 684.25 Million |
| Investment purchases | -2.91 Billion | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.45 Million | -1.45 Million | 23 Thousand | -518 Thousand | 1341.50 | -541 Thousand |
| Financing Cash Flow | 642.7 Thousand | 642.7 Thousand | 604.16 Million | 2.63 Billion | 973.13 Thousand | 6.38 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 44.25 Million | - | 610.81 Million | 622.4 Million | - | 11.59 Million |
| Other Financing Activities | 642.7 Thousand | 642.7 Thousand | - | 2.02 Billion | 973.13 Thousand | - |
| Accounts receivables | 12.55 Thousand | 12.55 Thousand | -25.08 Million | -25.01 Million | -12.54 Thousand | 69 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -11.04 Thousand | -11.04 Thousand | -81.09 Million | -55.37 Million | -38.22 Thousand | 25.72 Million |
| Cash at beginning of period | 3.26 Billion | - | 1.95 Billion | 1.64 Billion | 1.95 Million | 1.64 Billion |
| Cash at end of period | 1.2 Billion | -1.02 Million | 3.26 Billion | 3.26 Billion | 2.6 Million | 1.95 Billion |
| Capital Expenditure | -1760.00 | -1760.00 | -1.96 Million | -1.96 Million | -982.50 | - |
| Effect of forex changes on cash | 75.8 Thousand | 75.8 Thousand | - | -10.13 Million | -16.04 Thousand | - |
| Net cash flow / Change in cash | -2.05 Billion | -1.02 Million | 1.3 Billion | 1.61 Billion | 653.12 Thousand | 309.58 Million |
| Free Cash Flow | -289.16 Thousand | -289.16 Thousand | -607.97 Million | -1.01 Billion | -305.31 Thousand | -402.46 Million |
EEZY
6705
0KW1
2330
PSQH
NUVAMA